ENDRA Life Sciences Inc [NASDAQ: NDRA] closed the trading session at $8.3 on 2025-07-08. The day’s price range saw the stock hit a low of $7.0, while the highest price level was $11.96.
The stocks have a year to date performance of -94.79 percent and weekly performance of 136.47 percent. The stock has been moved at 28.88 percent over the last six months. The stock has performed 145.56 percent around the most recent 30 days and changed 134.46 percent over the most recent 3-months.
If compared to the average trading volume of 253.12K shares, NDRA reached to a volume of 90598869 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about ENDRA Life Sciences Inc [NDRA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NDRA shares is $46.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NDRA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 2.66, with the Price to Cash per share for the same quarter was set at 2.79.
NDRA stock trade performance evaluation
ENDRA Life Sciences Inc [NDRA] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 136.47. With this latest performance, NDRA shares gained by 145.56% in over the last four-week period, additionally plugging by 28.88% over the last 6 months – not to mention a rise of 32.59% in the past year of trading.
ENDRA Life Sciences Inc [NDRA]: An insightful look at the core fundamentals
Return on Equity for this stock declined to -237.35%, with Return on Assets sitting at -237.35%.
ENDRA Life Sciences Inc [NDRA]: Institutional Ownership
There are presently around $0.15%, or 0.15% of NDRA stock, in the hands of institutional investors.
